Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Prodigiosin development and its entrapped topical microstructured sunscreen for laser and UV radiation protection and antioxidant activity

Thaddeus Harrison Gugu1 , Anthony Amaechi Attama2, Emmanuel Chinedum Ibezim2, Ganesh Dinkarrao Basarkar3, Somchai Sawatdee4, Teerapol Srichana5

1Department of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka; 2Department of Pharmaceutics, University of Nigeria, Nsukka; 3Department of Pharmaceutics, SNJB's Shriman Sureshdada Jain College of Pharmacy, Chandwad, Savitribai Phule Pune University, Pune, Maharashtra State, India; 4Drug and Cosmetics Excellence Center and School of Pharmacy, Walailak University, Nakhon Si Thammarat 80161, Thailand; 5Drug Delivery System Excellence Center, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand.

For correspondence:-  Thaddeus Gugu   Email: thaddeus.gugu@unn.edu.ng   Tel:+234 8034152833

Received: 15 February 2025        Accepted: 21 July 2025        Published: 31 July 2025

Citation: Gugu TH, Attama AA, Ibezim EC, Basarkar GD, Sawatdee S, Srichana T. Prodigiosin development and its entrapped topical microstructured sunscreen for laser and UV radiation protection and antioxidant activity. Trop J Pharm Res 2025; 24(7):921-933 doi: https://dx.doi.org/10.4314/tjpr.v24i7.9

© 2025 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To develop prodigiosin (PG) cream for laser and ultraviolet radiation (UV) protection. Methods: The cream containing PG (PG-C) was prepared and characterized. In vivo skin irritation was evaluated on Wistar rats by shaving the animals and applying the calculated amount on the animal skin daily for 3 days, while occlusivity was carried out in vitro. Trans-epithelial water loss and melanin contents were evaluated in rats and antioxidant studies of PG were done using DPPH (0.1 mM) and ABTS (7 mM) protocols. In vitro drug release was conducted using dissolution tester and paddles. Furthermore, laser obscuration and sun protective factor (SPF) were screened. Results: The PG-C appeared pinkish with pH of 6.63 ± 0.21, viscosity of 2957 ± 2 Pa·s and spreadability of 36.85 g · cm/sec. There was no skin irritation during the 14-day treatment. Transmission electron microscope (TEM) and scanning electron microscopy (SEM) revealed the sizes of PG and PG-C to be 50 nm. The IC50 of PG was 28.74 ± 0.89 μg/mL (DPPH) and 11.9 ± 0.75 μg/mL (ABTS), while the average IC50 for PG-C was 21.33 ± 1.91 μg/mL (DPPH) and 24.0 ± 0.82 μg/mL (ABTS) with ascorbic acid at 43.89 ± 1.41 μg/mL. The PG-cream was able to block the laser and UV light. The PG release at 4 h from cream was 2 – 10 %. The loss of water content from human skin was minimal, while melanin content was not affected. Conclusion: This study has shown that PG-C offered protection against laser and UV light and demonstrates the presence of remarkable antioxidants.

Keywords: Prodigiosin, Sunscreen cream, Laser obscuration, Sun-protection factor, Antioxidant

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: